Open access
Open access
Powered by Google Translator Translator

Cardiology (all articles)

Cohort study: Intra-arrest transport vs. continued on-scene resuscitation in patients with out-of-hospital cardiac arrest

16 Sep, 2020 | 08:48h | UTC

Association of Intra-arrest Transport vs Continued On-Scene Resuscitation With Survival to Hospital Discharge Among Patients With Out-of-Hospital Cardiac Arrest – JAMA (free for a limited period)

Editorial: Challenging the “Scoop and Run” Model for Management of Out-of-Hospital Cardiac Arrest (free for a limited period)

Commentary: For Cardiac Arrest, Too-Hasty Transport Gets in the Way of Good CPR – MedPage Today (free registration required)

 

Commentary on Twitter

 

Cardiovascular magnetic resonance findings in competitive athletes recovering from COVID-19

14 Sep, 2020 | 01:14h | UTC

Cardiovascular Magnetic Resonance Findings in Competitive Athletes Recovering From COVID-19 Infection – JAMA Cardiology

Commentary: Athletes Have Telltale CMR Markers of Damage Post-COVID-19, but Clinical Significance Unclear – TCTMD

 

Commentary on Twitter (thread)

https://twitter.com/anish_koka/status/1304486340285935618

 

Consensus Statement: Cardio‐oncology care in the era of the COVID‐19 pandemic

14 Sep, 2020 | 00:54h | UTC

Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement – CA: A Cancer Journal for Clinicians

 

Commentary on Twitter

 

Systematic review: Blood pressure targets for the treatment of people with hypertension and cardiovascular disease

11 Sep, 2020 | 01:16h | UTC

Blood pressure targets for the treatment of people with hypertension and cardiovascular disease – Cochrane Library

Summary: Blood pressure targets in people with cardiovascular disease – Cochrane Library

 

Commentary on Twitter

 

[Abstract Only] Meta-analysis: Effects of intensive blood pressure treatment on orthostatic hypotension

11 Sep, 2020 | 01:14h | UTC

Effects of Intensive Blood Pressure Treatment on Orthostatic Hypotension – Annals of Internal Medicine

Commentary: Treating hypertension lowers the risk for orthostatic hypotension, or drop in blood pressure upon standing – American College of Physicians

 

Commentary on Twitter

 

COVID-19 is, in the end, an endothelial disease

8 Sep, 2020 | 01:11h | UTC

COVID-19 is, in the end, an endothelial disease – European Heart Journal

 

Commentary on Twitter

 

Systematic review: Reduction in saturated fat intake for cardiovascular disease

8 Sep, 2020 | 01:07h | UTC

Reduction in saturated fat intake for cardiovascular disease – Cochrane Library

Summary: Effect of cutting down on the saturated fat we eat on our risk of heart disease – Cochrane Library

 

Review: Optimal management of acute coronary syndromes in the era of COVID-19

8 Sep, 2020 | 01:09h | UTC

Optimal management of acute coronary syndromes in the era of COVID-19 – Heart

 

Podcast: Treatment of acute heart failure

8 Sep, 2020 | 01:00h | UTC

#230 Kittleson Rules Acute Heart Failure – The Curbsiders Internal Medicine Podcast

 

Post-COVID syndrome severely damages children’s hearts; ‘immense inflammation’ causing cardiac blood vessel dilation

6 Sep, 2020 | 22:03h | UTC

Post-COVID syndrome severely damages children’s hearts; ‘immense inflammation’ causing cardiac blood vessel dilation – University of Texas Health Science Center at San Antonio

Original Study: Multisystem inflammatory syndrome in children: A systematic review – EClinicalMedicine

 

Commentary on Twitter

 

Infographic. Clinical recommendations for return to play during the COVID-19 pandemic

6 Sep, 2020 | 21:54h | UTC

Infographic. Clinical recommendations for return to play during the COVID-19 pandemic – British Journal of Sports Medicine

 

Commentary on Twitter

 

Practical Guide: Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection

6 Sep, 2020 | 21:52h | UTC

Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: a practical guide for sport and exercise medicine physicians – British Journal of Sports Medicine

 

Commentary on Twitter

 

[Abstract Only] Randomized trial: Aspirin increases major GI bleeding risk by 60% in older individuals

6 Sep, 2020 | 21:30h | UTC

Major GI bleeding in older persons using aspirin: incidence and risk factors in the ASPREE randomised controlled trial – Gut

Source: EvidenceAlerts

 

Commentary on Twitter

 

COVID-19 can wreck your heart, even if you haven’t had any symptoms

3 Sep, 2020 | 11:06h | UTC

COVID-19 Can Wreck Your Heart, Even if You Haven’t Had Any Symptoms – Scientific American

 

Randomized trial: Similar outcomes with immediate angiography vs. delayed angiography after cardiac arrest

3 Sep, 2020 | 10:58h | UTC

Coronary Angiography After Cardiac Arrest Without ST Segment Elevation: One-Year Outcomes of the COACT Randomized Clinical Trial – JAMA Cardiology (free for a limited period)

Commentary: Angiography for Cardiac Arrest Survivors: No Need to Rush – MedPage Today (free registration required)

 

Commentary on Twitter

 

#ESCCongress – [Not Published Yet] First randomized trial backs safety of ACE Inhibitors and ARBs in COVID-19 patients

2 Sep, 2020 | 09:48h | UTC

News Release: First randomised trial backs safety of common heart drugs in COVID-19 patients – European Society of Cardiology

Commentary: Continuing Versus Suspending Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers – BRACE CORONA – American College of Cardiology

 

Commentary on Twitter

 

#ESCCongress – [Not Published Yet] Randomized trial on transfusion thresholds in anemic heart attack patients

2 Sep, 2020 | 09:42h | UTC

News Release: Trial clarifies use of blood transfusion in anaemic heart attack patients – European Society of Cardiology

Commentary: Randomized Trial of Transfusion Strategies in Patients With Myocardial Infarction and Anemia – REALITY – American College of Cardiology

 

Guideline synopsis: The diagnosis and management of hypertension in the primary care setting

2 Sep, 2020 | 09:38h | UTC

Synopsis of the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Clinical Practice Guideline: The Diagnosis and Management of Hypertension in the Primary Care Setting – Annals of Internal Medicine

 

Pulmonary hypertension: A brief guide for clinicians

2 Sep, 2020 | 09:34h | UTC

Pulmonary Hypertension: A Brief Guide for Clinicians – Mayo Clinic Proceedings

 

A current review of COVID-19 for the cardiovascular specialist

1 Sep, 2020 | 06:06h | UTC

A current review of COVID-19 for the cardiovascular specialist – American Heart Journal

 

#ESCCongress – [Abstract Only] Randomized trial: Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome

1 Sep, 2020 | 06:03h | UTC

Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial – The Lancet

Commentary: Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial – Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients – HOST-REDUCE-POLYTECH-ACS – American College of Cardiology

 

Commentary on Twitter

 

#ESCCongress – [Abstract Only] Randomized trial: Colchicine in patients with chronic coronary disease

1 Sep, 2020 | 06:04h | UTC

Colchicine in Patients with Chronic Coronary Disease – New England Journal of Medicine

Commentaries: LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease – TCTMD AND Low Dose Colchicine for Secondary Prevention of Cardiovascular Disease 2 – LoDoCo2 – American College of Cardiology

 

Commentary on Twitter

 

#ESCCongress – [Abstract Only] Randomized trial: Cardiovascular and renal outcomes with Empagliflozin in heart failure

31 Aug, 2020 | 01:38h | UTC

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure – New England Journal of Medicine

Commentaries: EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF – TCTMD AND EMPEROR-Reduced meets primary endpoint in heart failure with reduced ejection fraction – European Society of Cardiology AND Empagliflozin Outcome Trial in Patients With Chronic Heart Failure and a Reduced Ejection Fraction – EMPEROR-Reduced – American College of Cardiology

Related study: Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction – New England Journal of Medicine

 

Commentary on Twitter

 

#ESCCongress – [Abstract Only] Randomized trial: Early rhythm-control therapy in patients with atrial fibrillation

31 Aug, 2020 | 01:39h | UTC

Early Rhythm-Control Therapy in Patients with Atrial Fibrillation – New England Journal of Medicine

Commentaries: Early rhythm control therapy improves outcomes in patients with atrial fibrillation – European Society of Cardiology AND Rhythm Control Cuts First CV Events in Early Atrial Fibrillation: EAST-AFNET 4 – TCTMD AND Early Treatment of Atrial Fibrillation for Stroke Prevention Trial – EAST-AFNET 4 – American College of Cardiology AND EAST-AFNET 4: Is Early Rhythm-Control Therapy Associated With Lower Risk of CV Outcomes in Early AFIB Patients? – American College of Cardiology

 

Commentary on Twitter

 

#ESCCongress – [Abstract Only] Randomized trial: aspirin with or without clopidogrel after transcatheter aortic-valve implantation

31 Aug, 2020 | 01:33h | UTC

Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation – New England Journal of Medicine

Commentaries: Antiplatelet Therapy for Patients Undergoing Transcatheter Aortic-Valve Implantation – POPular TAVI (antiplatelet therapy) – American College of Cardiology AND Go With Aspirin Alone After TAVR When Anticoagulation Isn’t Needed: POPular TAVI – TCTMD

 

Commentary on Twitter

 

Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.